Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
16,463,909
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
24,839,747
-
Shares change
-
+2,149,354
-
Total reported value, excl. options
-
$731,027,543
-
Value change
-
+$65,328,555
-
Put/Call ratio
-
60.76%
-
Number of buys
-
69
-
Number of sells
-
-44
-
Price
-
$31.05
Significant Holders of RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) as of Q3 2021
147 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2021.
RAPT Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RAPT) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24,839,747 shares
.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (3,902,178 shares), PERCEPTIVE ADVISORS LLC (2,907,565 shares), BlackRock Inc. (1,898,821 shares), Ponoi Management, LLC (1,599,417 shares), WELLINGTON MANAGEMENT GROUP LLP (1,507,203 shares), KPCB XV Associates, LLC (1,297,063 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1,148,321 shares), FMR LLC (1,141,129 shares), VANGUARD GROUP INC (1,078,886 shares), and MORGAN STANLEY (763,744 shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.